Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Self-citationAlzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Self-citationCentral cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6)
Mesulam, M.-M., Mufson, E. J., Wainer, B. H., & Levey, A. I. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90108-2 · Cited by 2,328
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618
Alzheimer's disease: Targeting the Cholinergic System
H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,101
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Knapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,004
Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00025-3 · Cited by 938
Nucleus basalis and thalamic control of neocortical activity in the freely moving rat
Buzsaki, G., Bickford, R., Ponomareff, G., Thal, L., Mandel, R., & Gage, F. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04007.1988 · Cited by 848
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772
Rye, D. B., Wainer, B. H., Mesulam, M.-M., Mufson, E. J., & Saper, C. B. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90083-6 · Cited by 743
Šimić, G., Babić Leko, M., Wray, S., Harrington, C., Delalle, I., Jovanov-Milošević, N., Bažadona, D., Buée, L., De Silva, R., Di Giovanni, G., et al. (2016) · Biomolecules · doi:10.3390/biom6010006 · Cited by 703
Sherwin, B. B. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90060-1 · Cited by 703
Clinical trials of new drugs for Alzheimer disease
Huang, L.-K., Chao, S.-P., & Hu, C.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0609-7 · Cited by 702
Appel, S. H. (1981) · Annals of Neurology · doi:10.1002/ana.410100602 · Cited by 698
Optic-Nerve Degeneration in Alzheimer's Disease
Hinton, D. R., Sadun, A. A., Blanks, J. C., & Miller, C. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608213150804 · Cited by 694
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
Mesulam, M. ‐., & Mufson, E. J. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902120102 · Cited by 654
Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
Mufson, E. J., Counts, S. E., Perez, S. E., & Ginsberg, S. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1703 · Cited by 587
Heinrich, M., & Lee Teoh, H. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.02.012 · Cited by 584
Chronic ethanol consumption:from neuroadaptation to neurodegeneration
Fadda, F. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00032-x · Cited by 568
The cholinergic system and Parkinson disease
Bohnen, N. I., & Albin, R. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.048 · Cited by 566
The road to restoring neural circuits for the treatment of Alzheimer's disease
Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565
Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564
Possible Therapeutic Applications of Antagonists of Excitatory Amino acid Neurotransmitters
Meldrum, B. (1985) · Clinical Science · doi:10.1042/cs0680113 · Cited by 550
Salehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543
“Atrophy and loss of basal forebrain cholinergic neurons (BFCNs), a phenotype seen in AD, DS (Mann et al., 1985; Whitehouse et al., 1981), and several other neurodegenerative disorders (see Salehi et al., 1994), likely contributes to cognitive decline (Auld et al., 2002) but is poorly understood.”
Subcortical Dementia: Review of an Emerging Concept
Cummings, J. L. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050190080019 · Cited by 541
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Self-citationWidespread Expression of BDNF But Not NT3 by Target Areas of Basal Forebrain Cholinergic Neurons
Phillips, H. S., Hains, J. M., Laramee, G. R., Rosenthal, A., & Winslow, J. W. (1990) · Science · doi:10.1126/science.1688328 · Cited by 533
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 486
Self-citationPresence of both odor identification and detection deficits in alzheimer's disease
Doty, R. L., Reyes, P. F., & Gregor, T. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90129-8 · Cited by 476
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467
McKinney, M., Coyle, J. T., & Hedreen, J. C. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902170109 · Cited by 463
Self-citationCerebral Activity and Behavior: Control by Central Cholinergic and Serotonergic Systems
Vanderwolf, C. H. (1988) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60050-1 · Cited by 455
GSK-3β, a pivotal kinase in Alzheimer disease
Llorens-MarÃtin, M., Jurado, J., Hernández, F., & Ãvila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451
Acetylcholinesterase in Alzheimer's disease
Talesa, V. N. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00309-8 · Cited by 450
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
Rogawski, M. A., & Wenk, G. L. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00254.x · Cited by 436
A modified histochemical technique to visualize acetylcholinesterase-containing axons.
Hedreen, J. C., Bacon, S. J., & Price, D. L. (1985) · Journal of Histochemistry & Cytochemistry · doi:10.1177/33.2.2578498 · Cited by 434
Self-citationContribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426
Kuhl, D. E., Minoshima, S., Fessler, J. A., Ficaro, E. P., Wieland, D. M., Koeppe, R. A., Frey, K. A., & Foster, N. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400309 · Cited by 426
Stem cell‐based cell therapy in neurological diseases: A review
Kim, S. U., & de Vellis, J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22054 · Cited by 426
The cholinergic system in Alzheimer's disease
Kása, P., Rakonczay, Z., & Gulya, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00028-2 · Cited by 409
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
Sorbi, S., Bird, E. D., & Blass, J. P. (1983) · Annals of Neurology · doi:10.1002/ana.410130116 · Cited by 396
Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain
Zaborszky, L., Hoemke, L., Mohlberg, H., Schleicher, A., Amunts, K., & Zilles, K. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.055 · Cited by 393
Cholinesterase Inhibitors: A New Class of Psychotropic Compounds
Cummings, J. L. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.4 · Cited by 384
The Cholinergic Hypothesis: A Historical Overview, Current Perspective, and Future Directions
BARTUS, R. T., DEAN, R. L., PONTECORVO, M. J., & FLICKER, C. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb37600.x · Cited by 383
The basal ganglia and the locomotor regions
Garcia-Rill, E. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90009-3 · Cited by 378
Estrogen Replacement Therapy and Cognitive Function in Older Women
Barrett-Connor, E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500200051032 · Cited by 377
Alzheimer disease models and human neuropathology: similarities and differences
Duyckaerts, C., Potier, M.-C., & Delatour, B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 375
Temporal Lobe Regions on Magnetic Resonance Imaging Identify Patients With Early Alzheimer's Disease
Killiany, R. J., Moss, M. B., Albert, M. S., Sandor, T., Tieman, J., & Jolesz, F. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540090052010 · Cited by 373
FLICKER, C., DEAN, R., WATKINS, D., FISHER, S., & BARTUS, R. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(83)80023-9 · Cited by 370
Liu, A. K. L., Chang, R. C.-C., Pearce, R. K. B., & Gentleman, S. M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1392-5 · Cited by 368
Scopolamine model of dementia: electroencephalogram findings and cognitive performance
Ebert, & Kirch (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00393.x · Cited by 362
Acetylcholine, Aging, and Alzheimer's Disease
Muir, J. L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00431-5 · Cited by 360
Levey, A. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13541 · Cited by 359
Grady, C. L., Haxby, J. V., Horwitz, B., Sundaram, M., Berg, G., Schapiro, M., Friedland, R. P., & Rapoport, S. I. (1988) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638808402796 · Cited by 357
Inflammation and neurodegenerative diseases
Griffin, W. S. T. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.470s · Cited by 351
Savonenko, A., Xu, G. M., Melnikova, T., Morton, J. L., Gonzales, V., Wong, M. P. F., Price, D. L., Tang, F., Markowska, A. L., & Borchelt, D. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.022 · Cited by 346
Self-citationCurrent Pharmacotherapy for Alzheimer's Disease
Lleó, A., Greenberg, S. M., & Growdon, J. H. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131442 · Cited by 345
Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons
Yamamoto, T., & Hirano, A. (1985) · Annals of Neurology · doi:10.1002/ana.410170608 · Cited by 338
Moss, M. B., Albert, M. S., Butters, N., & Payne, M. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520030031008 · Cited by 335
Glutamate dysfunction in Alzheimer's disease: an hypothesis
Maragos, W. F., Greenamyre, J. T., Penney, J. B., & Young, A. B. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90025-7 · Cited by 334
Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina
Blanks, J. C., Torigoe, Y., Hinton, D. R., & Blanks, R. H. I. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00010-3 · Cited by 330
Cholinergic dysfunction in diseases with Lewy bodies
Tiraboschi, P., Hansen, L. A., Alford, M., Sabbagh, M. N., Schoos, B., Masliah, E., Thal, L. J., & Corey-Bloom, J. (2000) · Neurology · doi:10.1212/wnl.54.2.407 · Cited by 328
Transmitter deficits in Alzheimer's disease
Hardy, J., Adolfsson, R., Alafuzoff, I., Bucht, G., Marcusson, J., Nyberg, P., Perdahl, E., Wester, P., & Winblad, B. (1985) · Neurochemistry International · doi:10.1016/0197-0186(85)90050-6 · Cited by 328
Lang, R., Gundlach, A. L., Holmes, F. E., Hobson, S. A., Wynick, D., Hökfelt, T., & Kofler, B. (2015) · Pharmacological Reviews · doi:10.1124/pr.112.006536 · Cited by 327
Alzheimer's Disease and Mild Cognitive Impairment
Kelley, B. J., & Petersen, R. C. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.008 · Cited by 326
Melander, T., Staines, W. A., Hökfelt, T., Rökaeus, Å., Eckenstein, F., Salvaterra, P. M., & Wainer, B. H. (1985) · Brain Research · doi:10.1016/0006-8993(85)91228-4 · Cited by 318
NEURAL INPUTS INTO THE NUCLEUS BASALIS OF THE SUBSTANTIA INNOMINATA (Ch4) IN THE RHESUS MONKEY
MESULAM, M.-M., & MUFSON, E. J. (1984) · Brain · doi:10.1093/brain/107.1.253 · Cited by 316
Warden, M. K., & Young, W. S. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902720107 · Cited by 315
Pharmacokinetics and Pharmacodynamics in Clinical Use of Scopolamine
Renner, U. D., Oertel, R., & Kirch, W. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000168293.48226.57 · Cited by 314
Piecing together the Puzzle of Basal Forebrain Anatomy
Heimer, L., & Alheid, G. F. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-0145-6_1 · Cited by 310
Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology
Cummings, J. L. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.682 · Cited by 300
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
Lombardo, S., & Maskos, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.018 · Cited by 299
Murray, C. L., & Fibiger, H. C. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90273-8 · Cited by 299
Retinal ganglion cell degeneration in Alzheimer's disease
Blanks, J. C., Hinton, D. R., Sadun, A. A., & Miller, C. A. (1989) · Brain Research · doi:10.1016/0006-8993(89)90653-7 · Cited by 297
Substance P in the ascending cholinergic reticular system
Vincent, S. R., Satoh, K., Armstrong, D. M., & Fibiger, H. C. (1983) · Nature · doi:10.1038/306688a0 · Cited by 293
Chen, X.-Q., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00659 · Cited by 289
Heimer, L., Harlan, R. E., Alheid, G. F., Garcia, M. M., & de Olmos, J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00405-8 · Cited by 288
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
Kelly, S. C., He, B., Perez, S. E., Ginsberg, S. D., Mufson, E. J., & Counts, S. E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0411-2 · Cited by 286
“This study revealed that LC cell loss, which is prominent in cases of frank AD [19, 24, 36, 75, 86, 119], appears to occur early in the clinical progression of AD, concurrent with cell loss in the nucleus basalis and entorhinal cortex [7].”
The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress
Wenk, G. L. (1997) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.3757 · Cited by 286
Grothe, M., Heinsen, H., & Teipel, S. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.019 · Cited by 281
Mufson, E. J., Bothwell, M., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease
Vogels, O. J. M., Broere, C. A. J., Ter Laak, H. J., Ten Donkelaar, H. J., Nieuwenhuys, R., & Schulte, B. P. M. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90056-6 · Cited by 279
Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
Gaspar, P., & Gray, F. (1984) · Acta Neuropathologica · doi:10.1007/bf00695605 · Cited by 275
The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease
Cummings, J. L., & Back, C. (1998) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00009 · Cited by 274
Haxby, J. V., Grady, C. L., Duara, R., Schlageter, N., Berg, G., & Rapoport, S. I. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520090022010 · Cited by 270
Stewart, D. J., Macfabe, D. F., & Vanderwolf, C. H. (1984) · Brain Research · doi:10.1016/0006-8993(84)90112-4 · Cited by 270
The afferent connections of the substantia innominata in the monkey,Macaca fascicularis
Russchen, F. T., Amaral, D. G., & Price, J. L. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902420102 · Cited by 270
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G. (2009) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508328602 · Cited by 268
Cortical variability and asymmetry in normal aging and Alzheimer's disease
Thompson, P. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.6.492 · Cited by 266
The olfactory bulbs in Alzheimer's disease.
Esiri, M. M., & Wilcock, G. K. (1984) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.1.56 · Cited by 264
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.